Journals / Abant Tıp Dergisi / 2016 / Cilt: 5 - Sayı: 2

Purinergic mechanisms in the nervous system: the role of adenosine triphosphate in the migraine pathophysiology

Sinir Sisteminde Pürinerjik Mekanizmalar: Adenozin Trifosfatın Migren Patofizyolojisindeki Rolü

Pages
132–152
Publication Date
2016-05-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the present review, functions of extracellular ATP and its purinoceptors in the migraine pathophysiology and new treatment approaches were discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Notwithstanding that adenosine 5'-triphosphate ATP is an intracellular energy source, it is an important neurotransmitter and co-transmitter which play a role in purinergic signaling when it get out of the cell.
📊
Key Findings & Data:Extracellular ATP is a signaling molecule in the most area of the body and it shows its effects via ionotropic P2X and metabotropic P2Y receptors in the central and peripheral nervous system.
💡
Conclusion & Impact:In the present review, functions of extracellular ATP and its purinoceptors in the migraine pathophysiology and new treatment approaches were discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Adenozin trifosfat · ağrı · trigeminovasküler sistem

Abstract

Notwithstanding that adenosine 5'-triphosphate ATP is an intracellular energy source, it is an important neurotransmitter and co-transmitter which play a role in purinergic signaling when it get out of the cell. Extracellular ATP is a signaling molecule in the most area of the body and it shows its effects via ionotropic P2X and metabotropic P2Y receptors in the central and peripheral nervous system. These purinergic receptors activated by ATP and other nucleotides demonstrate a wide distribution throughout the body. It is well established nowadays that ATP has function as a neurotransmitter in the central and peripheral nervous system and purinergic signaling plays a role in many physiological process and additionally in the pathological conditions such as pain, migraine and inflammation. Recently studies have showed that ATP has a role in initiation and propagation of somatic and visceral pains. ATP is able to initiate periferal pain signals via P2X3 and P2X2/3 receptors which are located primary afferent nerve terminals. When ATP activate these receptors, pain signals are produced by membrane depolarization via cation inflow to the cell. Transmission of pain signals from periferal to central are mediated by P2X2, P2X3 and P2X6 receptors which are located second order neurons. Although it has been known that main process in initiation of migraine pain is activation of the trigeminovascular system, pathophysiology of migraine is not yet completely understood. It has been claimed by studies recently that ATP may play a key role via its purinoceptors in migraine headache as well like somatic pains. In the present review, functions of extracellular ATP and its purinoceptors in the migraine pathophysiology and new treatment approaches were discussed.

Özet

Adenozin 5'-trifosfat ATP hücre içi enerji kaynağı olmasının yanında hücre dışına çıktığında pürinerjik haberleşmede rol oynayan önemli bir nörotansmitter ve ko-transmitterdir. Vücudun birçok bölümünde bir sinyal molekülü olan ekstrasellüler ATP, merkezi ve periferik sinir sisteminde etkisini iyonotropik P2X ve metabotropik P2Y reseptörleri aracılığı ile gösterir. ATP ve diğer nükleotitlerin aktive ettiği bu pürinerjik reseptörler tüm vücut boyunca dağılım gösterir. ATP' nin merkezi ve periferik sinir sisteminde bir nörotransmitter olarak işlevinin olduğu ve pürinerjik haberleşmenin birçok fizyolojik olayda ve ayrıca ağrı, migren ve inflamasyon gibi patofizyolojik durumlarda rol oynadığı günümüzde daha iyi bilinmektedir. Son zamanlarda yapılan çalışmalar ATP' nin somatik ve viseral ağrıların başlatılmasında ve iletilmesinde rolü olduğunu göstermektedir. ATP primer afferent sinir terminallerinde bulunan P2X3 ve P2X2/3 reseptörleri aracılığı ile periferik ağrı sinyallerini başlatabilmektedir. ATP bu reseptörleri aktive ettiğinde hücre içine hızlı bir katyon girişi ile membran depolarize olmakta ve ağrı sinyalleri oluşmaktadır. Ağrı sinyallerinin periferden merkeze aktarılmasına ise ikinci sıra nöronlarında bulunan P2X2, P2X3 ve P2X6 reseptörleri aracılık etmektedir. Migren ağrısının başlamasındaki asıl olayın trigeminovasküler sistemin aktivasyonu olduğu bilinmesine rağmen migren patofizyolojisi henüz anlaşılamamıştır. Son zamanlarda yapılan çalışmalarla somatik ağrılarda olduğu gibi bir viseral ağrı olan migren baş ağrısında da ATP' nin pürinoseptörleri aracılığı ile önemli bir rol oynayabileceği ileri sürülmektedir. Sunulan derlemede bir nörotransmitter olarak ekstrasellüler ATP ve pürinoseptörlerinin migren patofizyolojisindeki işlevleri ve yeni tedavi yaklaşımları tartışılmıştır.

🔖

Cite This Article

KILINÇ, E. (2016). Purinergic mechanisms in the nervous system: the role of adenosine triphosphate in the migraine pathophysiology. Abant Tıp Dergisi, Cilt: 5 - Sayı: 2, 132–152. https://ajindex.com/articles/448984

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Holton P. The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J Physiol 1959;145:494-504
  2. Edwards FA, Gibb AJ, Colquhoun D. ATP receptor-mediated synaptic currents in the central nervous system. Nature 1992;359:144-47
  3. Silinsky EM, Gerzanich V, Vanner SM. ATP mediates excitatory synaptic transmission in mammalian neurones. Br J Pharmacol 1992;106:762-63
  4. Evans RJ, Derkach V, Surprenant A. ATP mediates fast synaptic transmission in mammalian neurons. Nature 1992;357:503-05
  5. Burnstock G.Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 2006;27:166-76
  6. Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H. Purinergic signalling in the nervous system: an overview. Trends Neurosci 2009; 32:19-29
  7. Bulanova E, Bulfone-Paus S. P2 receptor-mediated signaling in mast cell biology. Purinergic Signal 2010;6:3-17
  8. Ralevic V, Dunn WR. Purinergic transmission in blood vessels. Auton Neurosci 2015;191:48-66
  9. Pankratov Y, Lalo U, Verkhratsky A, North RA. Vesicular release of ATP at central synapses. Pflugers Arch. 2006;452:589-97
  10. Sawada K, Echigo N, Juge N, Miyaji T, Otsuka M, Omote H, Yamamoto A, Moriyama Y. Identification of a vesicular nucleotide transporter. Proc Natl Acad Sci USA 2008;105:5683-86
  11. Zimmermann H. Ectonucleotidases in the nervous system. Novartis Found Symp 2006;276:113-28
  12. Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H. Purinergic signalling in the nervous system: an overview. Trends Neurosci 2009; 32:19-29
  13. Cieślak M, Czarnecka J, Roszek K, Komoszyński M. The role of purinergic signaling in the etiology of migraine and novel antimigraine treatment. Purinergic Signal 2015;11:307-16
  14. Lewis CJ, Ennion SJ, Evans RJ. P2 purinoceptor-mediated control of rat cerebral(pial) microvasculature; contribution of P2X and P2Y receptors. J. Physiol 2000; 527: 315-24
  15. Arulkumaran N, Unwin RJ, Tam FWK. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs 2011; 20: 897- 915
  16. Burnstock G. Purinergic receptors and pain. Curr Pharm Des 2009;15:1717- 35
  17. Abbracchio MP, Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Therap 1994; 64: 445-75
  18. Atkinson L, Batten TF, Deuchars J. P2X(2) receptor immunoreactivity in the dorsal vagal complex and area postrema of the rat. Neuroscience 2000;99:683-96
  19. Deuchars SA, Atkinson L, Brooke RE